series-a
Stage
1
Investors
About
Cumulus Oncology is an oncology drug development accelerator that curates and advances a portfolio of preclinical-stage cancer therapeutics, prioritising data-driven, milestone-based development and partnering/licensing to progress assets into clinical stages. The company is based in Edinburgh and focuses on precision oncology and de-risking early programs via targeted patient subgroup strategies.
Explore Cumulus Oncology's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.